Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Interventional Cardiac Electrophysiology
Metadata
Title
When cardiac resynchronization therapy isn’t
Author
Alan D. Bernstein
Publication date
01-08-2006
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 2/2006
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-006-9035-3

Other articles of this Issue 2/2006

Journal of Interventional Cardiac Electrophysiology 2/2006 Go to the issue

OriginalPaper

Permanent direct his bundle pacing does not induce ventricular dyssynchrony unlike conventional right ventricular apical pacing

Case Report

Delayed detection of ventricular tachycardia due to intradevice interactions by implantable atrio-ventricular pacer/cardioverter defibrillator

Case Report

Cerebral air embolization in the Electrophysiology Laboratory during Transseptal Catheterization: Curative treatment of acute left hemiparesis with prompt hyperbaric oxygen therapy

OriginalPaper

Atrial arrhythmias following ostial or circumferential pulmonary vein ablation

Case Report

Placement of a coronary sinus lead in a patient with dextrocardia and situs inversus

Case Report

Symptoms of advanced heart failure—A case for radiofrequency catheter ablation?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits